Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RPHM

Reneo Pharmaceuticals (RPHM) Stock Price, News & Analysis

Reneo Pharmaceuticals logo

About Reneo Pharmaceuticals Stock (NASDAQ:RPHM)

Advanced Chart

Key Stats

Today's Range
$1.68
$1.90
50-Day Range
$1.31
$1.82
52-Week Range
$0.98
$9.21
Volume
437,523 shs
Average Volume
250,384 shs
Market Capitalization
$60.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RPHM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reneo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

RPHM Stock News Headlines

Onkure Therapeutics Inc (OKUR)
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

RPHM Stock Analysis - Frequently Asked Questions

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) posted its quarterly earnings results on Monday, March, 27th. The company reported ($0.56) earnings per share for the quarter, topping the consensus estimate of ($0.59) by $0.03.

Reneo Pharmaceuticals (RPHM) raised $101 million in an initial public offering (IPO) on Friday, April 9th 2021. The company issued 6,300,000 shares at $15.00-$17.00 per share. Jefferies, SVB Leerink and Piper Sandler served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Reneo Pharmaceuticals investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), Invesco QQQ (QQQ), JPMorgan Chase & Co. (JPM) and Netflix (NFLX).

Company Calendar

Last Earnings
3/27/2023
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RPHM
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$77.39 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$2.66 per share
Price / Book
0.68

Miscellaneous

Free Float
27,439,000
Market Cap
$60.84 million
Optionable
Optionable
Beta
0.21
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:RPHM) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners